Joseph Hull
Director/Board Member at PALATIN TECHNOLOGIES, INC.
Net worth: 34 868 $ as of 30/04/2024
Profile
Joseph Stanley Hull is an Independent Director at Palatin Technologies, Inc. since 2005.
He was previously a Senior Vice President-Pharmaceuticals at GlaxoSmithKline LLC from 1987 to 2010.
Before that, he was a VP & Director-Therapeutic Development at Glaxo Wellcome, Inc. Mr. Hull completed his undergraduate degree at The University of North Carolina at Greensboro.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
27/09/2023 | 20,272 ( 0.13% ) | 34 868 $ | 30/04/2024 |
Joseph Hull active positions
Companies | Position | Start |
---|---|---|
PALATIN TECHNOLOGIES, INC. | Director/Board Member | 15/09/2005 |
Former positions of Joseph Hull
Companies | Position | End |
---|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/05/2010 |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Training of Joseph Hull
The University of North Carolina at Greensboro | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PALATIN TECHNOLOGIES, INC. | Health Technology |
Private companies | 2 |
---|---|
Glaxo Wellcome, Inc. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Joseph Hull